Structural-stability studies on recombinant human transferrin

Author:

Kulakova A.ORCID,Indrakumar S.,Sønderby P.,Gentiluomo L.,Streicher W.,Roessner D.,Frieß W.,Peters G. H.J.,Harris P.ORCID

Abstract

AbstractTransferrin is an attractive candidate for drug delivery due to its ability to cross the blood brain barrier. However, in order to be able to use it for therapeutic purposes, it is important to investigate how its stability depends on different formulation conditions. Combining high-throughput thermal and chemical denaturation studies with small angle X-ray scattering (SAXS) and molecular dynamics (MD) simulations, it was possible to connect the stability of transferrin with its conformational changes. The release of iron induces opening of transferrin, which results in a negative effect on its stability. Presence of NaCl, arginine, and histidine leads to opening of the transferrin N-lobe and has a negative impact on the overall protein stability.Statement of significanceProtein-based therapeutics have become an essential part of medical treatment. They are highly specific, have high affinity and fewer off-target effects. However, stabilization of proteins is critical, time-consuming, and expensive, and it is not yet possible to predict the behavior of proteins under different conditions. The current work is focused on a molecular understanding of the stability ofhumanserum transferrin; a protein which is abundant in blood serum, may pass the blood brain barrier and therefore with high potential in drug delivery. Combination of high throughput unfolding techniques and structural studies, using small angle X-ray scattering and molecular dynamic simulation, allows us to understand the behavior of transferrin on a molecular level.

Publisher

Cold Spring Harbor Laboratory

Reference44 articles.

1. DrugBank: a comprehensive resource for in silico drug discovery and exploration

2. Instability, stabilization, and formulation of liquid protein pharmaceuticals

3. Shen, W. , Y. Liu , and H. Wang . 2019. Insulin-transferrin fusion protein and its prodrug, proinsulin-transferrin, for overcoming insulin resistance. World Pat. WO/2019/014552.

4. Yoon, J.-H. , B.-H. Chang , S.N. Kim , I.-H. Jeong , K.S. Park , and K.-Y. Nam . 2018. Pharmaceutical composition comprising mutant human growth hormone protein or transferrin fusion protein thereof as effective ingredient. World Pat. WO/2018/004294..

5. Wang, B. , and J. Turner, Andrew . 2006. Anchored transferrin fusion protein libraries. World Pat. WO/2006/138700.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3